Видео ютуба по тегу Michael Winlo

Emyria Updates JustStocks Video On Clinical Services Milestones and Development Pipeline
Emyria Updates JustStocks Video On Clinical Services Milestones and Development Pipeline
Psychedelic Therapies in Australia: Achievements, Challenges and Opportunities
Psychedelic Therapies in Australia: Achievements, Challenges and Opportunities
Emyria opens Empax Centre to target care gaps in resistant PTSD
Emyria opens Empax Centre to target care gaps in resistant PTSD
Emyria MD Speaks with JustStocks Following Official Launch Of New Empax Centre
Emyria MD Speaks with JustStocks Following Official Launch Of New Empax Centre
Emyria MD Tells JustStocks Second Specialist has Been Approved for MDMA-Assisted Therapy Program
Emyria MD Tells JustStocks Second Specialist has Been Approved for MDMA-Assisted Therapy Program
Emyria (ASX:EMD): TSN's ASX Gems Investment Conference presentation
Emyria (ASX:EMD): TSN's ASX Gems Investment Conference presentation
Emyria (ASX:EMD): TSN - The Stock Network presentation
Emyria (ASX:EMD): TSN - The Stock Network presentation
Emyria welcomes top healthcare leader as chairman
Emyria welcomes top healthcare leader as chairman
Emyria set to begin MDMA study after securing local supply
Emyria set to begin MDMA study after securing local supply
Emyria Ltd: So crazy it might just work – psychedelic drugs to treat mental health
Emyria Ltd: So crazy it might just work – psychedelic drugs to treat mental health
Emyria (ASX:EMD) Managing Director Dr Michael Winlo
Emyria (ASX:EMD) Managing Director Dr Michael Winlo
Emyria provides unique combination of drug development and therapy delivery
Emyria provides unique combination of drug development and therapy delivery
Emyria advances development and commercialisation of unique drug products
Emyria advances development and commercialisation of unique drug products
Emyria recruits first patient for MDMA-assisted therapy trial
Emyria recruits first patient for MDMA-assisted therapy trial
Emyria expands mental health care capabilities with Pax Centre acquisition
Emyria expands mental health care capabilities with Pax Centre acquisition
Emyria hails ethics approval for MDMA-assisted clinical trial
Emyria hails ethics approval for MDMA-assisted clinical trial
Emyria launches new high potency Ultra-Pure CBD capsule
Emyria launches new high potency Ultra-Pure CBD capsule
Emyria Q & A - Aspen & Emyria - A Winning Partnership!
Emyria Q & A - Aspen & Emyria - A Winning Partnership!
Emyria agrees licensing and commercialisation deal for EMD-RX5
Emyria agrees licensing and commercialisation deal for EMD-RX5
Emyria (ASX:EMD) - Broker Briefing Biotech & Nutrition Investor Webinar - March 2023
Emyria (ASX:EMD) - Broker Briefing Biotech & Nutrition Investor Webinar - March 2023